Morocco's Ministry of Health announced on Monday that it will continue vaccinating its 60 and over population with China's COVID-19 vaccine developed by Sinopharm, adding that available data is in line with the country's national vaccination strategy. 

In a statement, the ministry described the vaccine as excellent, with a seroconversion rate ranging between 97 percent and 100 percent after two injections.